Unfreezing US FDA: Generic Drug Officials Make Plea For Public Workshops

The FDA generic drugs team’s first public workshop of the second Trump Administration ended with a request that industry amplify the value it finds from public engagement.

OGD wants industry to amplify the perceived value of FDA public meetings. (Shutterstock)

More from Regulation

More from Products